Tauriga Sciences, Inc. Successfully Registers on BidNet Direct and is Actively Bidding on U.S. Government Contract(s)
April 01, 2021 06:36 ET | Tauriga Sciences
The Company is a Verified Federal Government Vendor (CAGE CODE # 8QXV4) NEW YORK, NY, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the...
Screen Shot 2021-02-17 at 8.20.26 AM.png
Tauriga Sciences Inc. Announces Upcoming Commercial Launch of its Enhanced, 25mg CBD & CBG Infused, Version of Tauri-Gum
March 26, 2021 13:02 ET | Tauriga Sciences
NEW YORK, NY, March 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...
Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
March 24, 2021 11:34 ET | Tauriga Sciences
Commercial Launch of Tauri-Pet™ Product Line is Anticipated: April 20, 2021  NEW YORK, NY, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or...
Tauriga Sciences Inc. Files International Patent Application, Relating to its Proposed Pharmaceutical Cannabinoid Chewing Gum, Under the Patent Cooperation Treaty
March 22, 2021 08:10 ET | Tauriga Sciences
NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...
Screen Shot 2021-02-17 at 8.20.26 AM.png
Tauriga Sciences, Inc. Converts its U.S. Provisional Patent Application (Filed on March 17, 2020) to a U.S. Non-Provisional Patent Application
March 22, 2021 06:18 ET | Tauriga Sciences
To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW...
Screen Shot 2021-02-17 at 8.20.26 AM.png
Tauriga Sciences Inc. Enters into 6 Month Agreement with Coalition Technologies to Enhance its Search Engine Optimization Metrics
March 19, 2021 10:26 ET | Tauriga Sciences
The Company is Focused on Both Increasing Tauri-Gum™ Brand Awareness and E-Commerce Revenue NEW YORK, NY, March 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)...
Screen Shot 2021-02-17 at 8.20.26 AM.png
Tauriga Sciences Inc. Commences Development of Delta-8-THC Infused Version of Tauri-Gum
March 17, 2021 09:03 ET | Tauriga Sciences
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...
Tauriga Sciences Inc. Assembles Territorial On-the-Ground Sales Force, Initially Focused on Seven U.S. Cities
March 15, 2021 11:57 ET | Tauriga Sciences
The Company’s Assembling of this Sales Force Coincides with Launch of its Increased Tauri-Gum™ CBD & CBG Infusion Concentrations (25mg/per Serving) NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE)...
Screen Shot 2021-02-17 at 8.20.26 AM.png
Tauriga Sciences Inc. Completely Free of Convertible Debt
March 15, 2021 08:53 ET | Tauriga Sciences
The Company Has Fully Repaid and Retired Its Final Outstanding Convertible Debenture NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE) --  via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)...
Tauriga Sciences Inc. Completes Payment for the Entirety of its Recently Announced - Largest Tauri-Gum Production Run in Company History
March 09, 2021 11:05 ET | Tauriga Sciences
This Production Run Incorporates the Increased CBD & CBG Infusion Concentrations (25mg per Each Piece of Chewing Gum) NEW YORK, NY, March 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --...